| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Axitinib | SIDER | ||
| 2 | Cefazolin | SIDER | ||
| 3 | Cefepime | SIDER | ||
| 4 | Cefuroxime | SIDER | ||
| 5 | Ciprofloxacin | SIDER | ||
| 6 | Deferoxamine | SIDER | ||
| 7 | Eptifibatide | SIDER | ||
| 8 | Erlotinib Hydrochloride | SIDER | ||
| 9 | Fentanyl | SIDER | ||
| 10 | Gadobenic acid | SIDER | ||
| 11 | Itraconazole | SIDER | ||
| 12 | Mesalamine | SIDER | ||
| 13 | Olanzapine | SIDER | ||
| 14 | Pioglitazone | SIDER | ||
| 15 | exemestane | SIDER | ||
| 16 | mersyndol | SIDER | ||
| 17 | tipranavir | SIDER | ||
| 18 | ziprasidone | SIDER |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120265
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.